Full-Time
RapidAI
201-500 employees
AI software for vascular condition detection
No salary listed
Expert
Bengaluru, Karnataka, India
Hybrid position requiring some in-office days.
- Master’s degree or equivalent, in Computer Science, Bioengineering, Electrical Engineering, Physics, Theoretical or Applied Math or related engineering fields.
- Total 17+ years and 6+ years of experience with algorithm development (employee participation in a PhD program in engineering fields directly related to the medical software algorithm development counts towards the years of experience).
- Conceives, develops and implements algorithms for medical datasets analysis, including CT, MR, Ultrasound, 3D rotational angiography (3D RA).
- Conceives, develops and implements algorithms that statistically evaluate features, attributes and labels from large number of datasets, and presents the statistical summaries.
- Conceives, develops and implements algorithms based on machine learning, artificial intelligence and deep learning to extract features, attributes and labels from medical imaging datasets and related metaheaders and clinical records.
- Conceives, develops and implements algorithms to verify and validate results of other algorithms and image-processing modules.
- Creates and reviews technical and scientific documentation related to the algorithms and image-processing modules.
- Develops algorithms and statistical models that report, analyze and validate performance and accuracy of algorithmic methods and image-processing modules.
- Provides training, education and supervision of other employees and team members, creating documents, presentations and reports, and supervising more junior members of the algorithm team.
- Supports team members in deployment, regular use and troubleshooting of algorithms and image-processing modules.
With a pivotal role in enhancing clinical decision-making, this company offers a robust AI-driven platform that assists in detecting and managing severe vascular and neurovascular conditions. Leveraging intelligence from over 10 million scans, it empowers healthcare professionals in more than 2,000 hospitals to make quicker, more informed decisions. Working here not only places you at the forefront of medical technology partnerships but also within a culture dedicated to impactful innovation and elevated patient care.
Company Size
201-500
Company Stage
Series C
Total Funding
$100.5M
Headquarters
Menlo Park, California
Founded
2012
Simplify's Take
What believers are saying
- RapidAI's partnership with Alaska Stroke Coalition improves stroke care in rural areas.
- The company won the 2024 MedTech Breakthrough Award for 'Best Care Coordination Platform'.
- FDA clearance for AngioFlow™ enhances RapidAI's stroke imaging capabilities in the U.S.
What critics are saying
- Emerging AI healthcare startups could threaten RapidAI's market share.
- RapidAI's solutions may become outdated without continuous innovation.
- Data privacy concerns could arise as RapidAI expands globally.
What makes RapidAI unique
- RapidAI's platform uses AI to enhance stroke and aneurysm diagnostic imaging.
- The company offers a centralized platform for remote access to critical patient information.
- RapidAI's solutions facilitate collaborative decision-making among healthcare providers.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Sick Leave
Paid Holidays
401(k) Retirement Plan
401(k) Company Match
Stock Options
Phone/Internet Stipend
Hybrid Work Options
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↑ 0%What You Should Know:– RapidAI, a global leader in AI-powered healthcare solutions, has announced a partnership with the Alaska Stroke Coalition (ASC) to improve stroke care in Alaska.– The “Rapid AK” project aims to address the unique challenges faced by rural hospitals in the state, such as limited technology and access to specialized care.The Importance of Timely Stroke TreatmentStroke is a leading cause of death and disability in Alaska. Every minute a stroke goes untreated, 1.9 million brain cells die, leading to significant long-term consequences. The ASC is dedicated to improving stroke outcomes by enhancing prevention, treatment, and rehabilitation efforts.Leveraging AI to Enhance Stroke CareRapidAI’s AI-powered solutions offer a number of benefits for stroke care, including:Clinical insights: RapidAI’s technology can provide valuable insights into CT scans, helping healthcare providers identify salvageable brain tissue.RapidAI’s technology can provide valuable insights into CT scans, helping healthcare providers identify salvageable brain tissue. Centralized workflow: A centralized platform allows the entire care team to access critical patient information, even across remote locations.A centralized platform allows the entire care team to access critical patient information, even across remote locations. Collaborative decision-making: The platform facilitates collaboration among healthcare providers, enabling more effective treatment planning.Addressing the Challenges of Rural Stroke CareRural hospitals in Alaska face unique challenges in providing timely stroke care. By implementing RapidAI’s solutions, these hospitals can improve their ability to diagnose and treat strokes, even in remote locations.The partnership between RapidAI and the ASC has the potential to significantly improve stroke outcomes in Alaska
RapidAI partners with Alaska Stroke Coalition.
RapidAI Acquires Comprehensive Aneurysm Management Innovator and Expands Scope to Include Aneurysm, Extending Its Leadership in Cerebrovascular Imaging
LOS ANGELES, June 06, 2024 (GLOBE NEWSWIRE) -- MedTech Breakthrough , an independent market intelligence organization that recognizes the top companies, technologies, and products in the global digital health and medical technology market, today announced that RapidAI , the global leader in developing Artificial Intelligence (AI) and clinical workflow solutions to combat life-threatening neurovascular, cardiac, and vascular diseases, has been selected as the winner of the “Best Care Coordination Platform” award in the 8th annual MedTech Breakthrough Awards program.The 2024 MedTech Breakthrough Award recognizes the breakthrough innovation of the RapidAI Clinical Platform, a proven solution that provides clinicians from thousands of hospitals in over 100 countries with deep clinical context to make faster and more informed treatment decisions while also enhancing their confidence in diagnosis. By opening up the care pathway through the power of AI and enhanced connectivity, RapidAI transforms the quality of care delivered to patients by facilitating faster, more informed decision-making.“RapidAI’s Clinical Platform moves the needle by pairing together the most clinically validated deep AI algorithms with workflow efficiencies that take the friction out of the healthcare system, making it our ‘Best Care Coordination Platform’ for 2024,” said Steve Johansson, managing director of MedTech Breakthrough. “The workflow efficiencies and connectivity that RapidAI enables ensures that every patient, no matter where they go for care, has access to the most trusted technology and clinical specialists - all while delivering measurable financial and operational impact.”According to the World Stroke Organization (WSO), over 100 million people in the world have experienced a stroke, of which over half will die as a result. On top of this, the WSO estimates 143 million healthy years of life are lost for those who do survive. For stroke patients alone, RapidAI’s technology has been shown to reduce both length-of-stay and non-fatal complications, increase mechanical thrombectomy procedure volume, reduce the number of costly futile transfers, and give radiologists and hospital staff valuable time back through its cutting-edge AI and workflow solution.“We are honored that the RapidAI Clinical Platform has been recognized by MedTech Breakthrough for the care orchestration and workflow efficiencies that it enables,” said Karim Karti, CEO of RapidAI. “By enhancing cross-department collaboration and team communication, the RapidAI Clinical Platform benefits care teams by fostering prompt collaboration and mitigating wasted time and resources
SAN MATEO, Calif.--(BUSINESS WIRE)--RapidAI, the global leader in developing clinically deep Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, cardiac, and vascular diseases, today announced that the Food and Drug Administration (FDA) has granted 510(k) clearance for its AngioFlow™ by RapidAI solution. The module delivers perfusion imaging analysis directly within the interventional suite to promote greater clinical confidence, workflow efficiency, and potentially improve patient outcomes. “We are pleased to expand our stroke AI imaging portfolio, the broadest in the industry, to include this new module. With AngioFlow™ by RapidAI, we can now support stroke AI imaging along the entire patient pathway, from the initial non-contrast CT scan all the way to the interventional suite,” said Karim Karti, CEO of RapidAI. “Already registered and used in Japan and Europe, we believe this technology will make a significant difference in the lives of U.S. stroke patients.”